Executive function and depressive symptoms of retardation in nonelderly stroke patients

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSOBREIRO, Matildes F. M.
dc.contributor.authorMIOTTO, Eliane Correa
dc.contributor.authorTERRONI, Luisa
dc.contributor.authorTINONE, Gisela
dc.contributor.authorIOSIFESCU, Dan V.
dc.contributor.authorLUCIA, Mara C. S. de
dc.contributor.authorSCAFF, Milberto
dc.contributor.authorLEITE, Claudia da Costa
dc.contributor.authorAMARO JR., Edson
dc.contributor.authorFRAGUAS, Renerio
dc.date.accessioned2014-09-30T14:42:28Z
dc.date.available2014-09-30T14:42:28Z
dc.date.issued2014
dc.description.abstractThe depression-executive dysfunction syndrome, a late-onset depression of vascular origin with executive dysfunction and psychomotor retardation, has also been described after stroke. We verified whether this syndrome also occurs in nonelderly stroke patients by investigating the association between domains of depressive symptoms with executive functions in 87 first-ever ischemic stroke patients. The retardation domain of the 31-item Hamilton Rating Scale for Depression was associated with decreased performance on verbal fluency (assessed with FAS). The association was maintained for younger patients (aged <60 years) after adjusting for confounders. This result supports the clinical presentation of depression-executive dysfunction syndrome in younger stroke patients. Confirmation of this finding, its neural correlates, and clinical implication deserve further investigation.
dc.description.indexMEDLINE
dc.description.sponsorshipIcahn School of Medicine at Mount Sinai from National Institute of Mental Health - NIMH (NIH)
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipBrainsway
dc.description.sponsorshipEuthymics
dc.description.sponsorshipNeosync
dc.description.sponsorshipRoche
dc.description.sponsorshipAvanir
dc.description.sponsorshipCNS Response
dc.description.sponsorshipOtsuka
dc.description.sponsorshipLundbeck
dc.description.sponsorshipServier
dc.description.sponsorshipSunovion
dc.identifier.citationJOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, v.36, n.6, p.636-647, 2014
dc.identifier.doi10.1080/13803395.2014.925092
dc.identifier.eissn1744-411X
dc.identifier.issn1380-3395
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/7550
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS INC
dc.relation.ispartofJournal of Clinical and Experimental Neuropsychology
dc.rightsrestrictedAccess
dc.rights.holderCopyright TAYLOR & FRANCIS INC
dc.subjectExecutive functions
dc.subjectDepressive symptoms
dc.subjectStroke
dc.subjectNeuropsychological tests
dc.subjectVascular depression
dc.subject.otherlate-life depression
dc.subject.othervascular cognitive impairment
dc.subject.otherwhite-matter hyperintensities
dc.subject.otherhuman cerebral-cortex
dc.subject.otherpoststroke depression
dc.subject.otherdysfunction syndrome
dc.subject.otherfollow-up
dc.subject.otherneuropsychological deficits
dc.subject.otherantidepressant-treatment
dc.subject.otherclinical determinants
dc.subject.wosPsychology, Clinical
dc.subject.wosClinical Neurology
dc.subject.wosPsychology
dc.titleExecutive function and depressive symptoms of retardation in nonelderly stroke patients
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.author.externalIOSIFESCU, Dan V.:Icahn Sch Med Mt Sinai, Mood & Anxiety Disorders Program, New York, NY 10029 USA
hcfmusp.citation.scopus5
hcfmusp.contributor.author-fmusphcMATILDES DE FREITAS MENEZES SOBREIRO
hcfmusp.contributor.author-fmusphcELIANE CORREA MIOTTO
hcfmusp.contributor.author-fmusphcLUISA DE MARILLAC NIRO TERRONI
hcfmusp.contributor.author-fmusphcGISELA TINONE
hcfmusp.contributor.author-fmusphcMARA CRISTINA SOUZA DE LUCIA
hcfmusp.contributor.author-fmusphcMILBERTO SCAFF
hcfmusp.contributor.author-fmusphcCLAUDIA DA COSTA LEITE
hcfmusp.contributor.author-fmusphcEDSON AMARO JUNIOR
hcfmusp.contributor.author-fmusphcRENERIO FRAGUAS JUNIOR
hcfmusp.description.beginpage636
hcfmusp.description.endpage647
hcfmusp.description.issue6
hcfmusp.description.volume36
hcfmusp.origemWOS
hcfmusp.origem.pubmed24974834
hcfmusp.origem.scopus2-s2.0-84903695292
hcfmusp.origem.wosWOS:000338987200008
hcfmusp.publisher.cityPHILADELPHIA
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAlexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P98, DOI 10.1176/appi.ajgp.10.1.98
hcfmusp.relation.referenceAlexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929
hcfmusp.relation.referenceAlexopoulos GS, 2001, AM J GERIAT PSYCHIAT, V9, P22, DOI 10.1176/appi.ajgp.9.1.22
hcfmusp.relation.referenceAlexopoulos GS, 1997, AM J PSYCHIAT, V154, P562
hcfmusp.relation.referenceAlves TCTF, 2007, PSYCHOSOMATICS, V48, P22, DOI 10.1176/appi.psy.48.1.22
hcfmusp.relation.reference*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT
hcfmusp.relation.referenceBallard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994
hcfmusp.relation.referenceBenton AL, 1989, MULTILINGUAL APHASIA
hcfmusp.relation.referenceBOLLAWILSON K, 1989, AM J PSYCHIAT, V146, P627
hcfmusp.relation.referenceBour A, 2011, INT J GERIATR PSYCH, V26, P679, DOI 10.1002/gps.2581
hcfmusp.relation.referenceBrandao E., 1997, THESIS SAO PAULO PON
hcfmusp.relation.referenceBrunoni AR, 2013, PSYCHONEUROENDOCRINO, V38, P58, DOI 10.1016/j.psyneuen.2012.04.020
hcfmusp.relation.referenceBueno VF, 2011, NEUROCASE, V17, P318, DOI 10.1080/13554794.2010.509319
hcfmusp.relation.referenceCharchat-Fichman H, 2009, ARQ NEURO-PSIQUIAT, V67, P445, DOI 10.1590/S0004-282X2009000300014
hcfmusp.relation.referenceDucan M. T., 2006, J BRAS PSIQUIAT, V55, P42
hcfmusp.relation.referenceEVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813
hcfmusp.relation.referenceFinkenzeller W, 2009, NERVENARZT, V80, P805, DOI 10.1007/s00115-008-2649-1
hcfmusp.relation.referenceFirst MB, 1995, STRUCTURED CLIN INTE
hcfmusp.relation.referenceFossati P, 2002, J AFFECT DISORDERS, V68, P261, DOI 10.1016/S0165-0327(00)00362-1
hcfmusp.relation.referenceFriston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156
hcfmusp.relation.referenceHAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
hcfmusp.relation.referenceHobson P, 2010, J STROKE CEREBROVASC, V19, P382, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.006
hcfmusp.relation.referenceHouse A, 2001, STROKE, V32, P696
hcfmusp.relation.referenceIosifescu DV, 2005, PSYCHOSOM MED, V67, P703, DOI 10.1097/01.psy.0000170338.75346.d0
hcfmusp.relation.referenceIosifescu DV, 2006, BRIT J PSYCHIAT, V188, P180, DOI 10.1192/bjp.188.2.180
hcfmusp.relation.referenceJamerson Brenda D, 2003, Psychopharmacol Bull, V37, P67
hcfmusp.relation.referenceJohnson JK, 2007, J GERONTOL A-BIOL, V62, P1134
hcfmusp.relation.referenceJones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748
hcfmusp.relation.referenceKauhanen ML, 1999, STROKE, V30, P1875
hcfmusp.relation.referenceKimura M, 2002, INT CLIN PSYCHOPHARM, V17, P121, DOI 10.1097/00004850-200205000-00005
hcfmusp.relation.referenceKimura M, 2000, STROKE, V31, P1482
hcfmusp.relation.referenceKotila M, 1999, EUR J NEUROL, V6, P309, DOI 10.1046/j.1468-1331.1999.630309.x
hcfmusp.relation.referenceKrishnan KRR, 1997, AM J PSYCHIAT, V154, P497
hcfmusp.relation.referenceLesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262
hcfmusp.relation.referenceLezak M.D., 1995, NEUROPSYCHOLOGICAL A
hcfmusp.relation.referenceLockwood KA, 2002, AM J PSYCHIAT, V159, P1119, DOI 10.1176/appi.ajp.159.7.1119
hcfmusp.relation.referenceMcIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063
hcfmusp.relation.referenceMead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2
hcfmusp.relation.referenceMelkas S, 2010, AM J GERIAT PSYCHIAT, V18, P1007, DOI 10.1097/JGP.0b013e3181d695d7
hcfmusp.relation.referenceMeusel LAC, 2013, PSYCHIAT RES-NEUROIM, V214, P142, DOI 10.1016/j.pscychresns.2013.06.007
hcfmusp.relation.referenceMurata Y, 2000, AM J GERIAT PSYCHIAT, V8, P310, DOI 10.1176/appi.ajgp.8.4.310
hcfmusp.relation.referenceNaarding P, 2003, INT J GERIATR PSYCH, V18, P325, DOI 10.1002/gps.831
hcfmusp.relation.referenceNarushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157
hcfmusp.relation.referenceNarushima K, 2007, BRIT J PSYCHIAT, V190, P260, DOI 10.1192/bjp.bp.106.025064
hcfmusp.relation.referenceNyenhuis DL, 2004, CLIN NEUROPSYCHOL, V18, P41, DOI 10.1080/13854040490507145
hcfmusp.relation.referenceNys GMS, 2005, J INT NEUROPSYCH SOC, V11, P795, DOI 10.1017/S1355617705050952
hcfmusp.relation.referenceNys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464
hcfmusp.relation.referenceNys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005
hcfmusp.relation.referenceNys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031
hcfmusp.relation.referenceO'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3
hcfmusp.relation.referencePapakostas GI, 2005, PSYCHIAT RES-NEUROIM, V140, P301, DOI 10.1016/j.pscychresns.205.09.001
hcfmusp.relation.referencePohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x
hcfmusp.relation.referencePohjasvaara T, 1997, STROKE, V28, P785
hcfmusp.relation.referencePohjasvaara T, 1998, STROKE, V29, P2311
hcfmusp.relation.referencePorter RJ, 2013, AUST NZ J PSYCHIAT, V47, P1165, DOI 10.1177/0004867413502090
hcfmusp.relation.referenceProkopenko SV, 2013, J NEUROL SCI, V325, P148, DOI 10.1016/j.jns.2012.12.024
hcfmusp.relation.referenceRasquin SMC, 2009, NEUROPSYCHOL REHABIL, V19, P208, DOI 10.1080/09602010802091159
hcfmusp.relation.referenceRobinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142
hcfmusp.relation.referenceRorden C, 2000, BEHAV NEUROL, V12, P191
hcfmusp.relation.referenceRorden C., 2005, MRICRO SOFTWARE
hcfmusp.relation.referenceSato S, 2006, PSYCHIAT CLIN NEUROS, V60, P584, DOI 10.1111/j.1440-1819.2006.01562.x
hcfmusp.relation.referenceSchramke CJ, 1998, J CLIN EXP NEUROPSYC, V20, P723, DOI 10.1076/jcen.20.5.723.1117
hcfmusp.relation.referenceSheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204
hcfmusp.relation.referenceSpreen O, 1991, COMPENDIUM NEUROPSYC
hcfmusp.relation.referenceStatistical Parametric Mapping (SPM5), 2005, COMPUTER SOFTWARE
hcfmusp.relation.referenceStroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651
hcfmusp.relation.referenceTalairach J, 1988, COPLANAR STEREOTAXIC
hcfmusp.relation.referenceTATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202
hcfmusp.relation.referenceTaylor WD, 2003, ARCH GEN PSYCHIAT, V60, P1090, DOI 10.1001/archpsyc.60.11.1090
hcfmusp.relation.referenceTerroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242
hcfmusp.relation.referenceTerroni LDN, 2009, REV BRAS PSIQUIATR, V31, P202, DOI 10.1590/S1516-44462009000300004
hcfmusp.relation.referenceTombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4
hcfmusp.relation.referenceTrivedi MH, 2013, AM J PSYCHIAT, V170, P633, DOI 10.1176/appi.ajp.2012.12020250
hcfmusp.relation.referenceVanEssen DC, 1997, J NEUROSCI, V17, P7079
hcfmusp.relation.referenceVan Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788
hcfmusp.relation.referenceVataja R, 2005, AM J GERIAT PSYCHIAT, V13, P99, DOI 10.1176/appi.ajgp.13.2.99
hcfmusp.relation.referenceVerdelho A, 2004, NEUROLOGY, V62, P905
hcfmusp.relation.referenceWechsler D., 1981, WECHSLER ADULT INTEL
hcfmusp.relation.referenceWilliamson J, 2010, J CLIN EXP NEUROPSYC, V32, P673, DOI 10.1080/13803390903427406
hcfmusp.relation.referenceWorld Health Organization, 1989, STROKE, V20, P1407
hcfmusp.relation.referenceYochim BP, 2006, J CLIN EXP NEUROPSYC, V28, P495, DOI 10.1080/13803390590949322
hcfmusp.relation.referenceZhou B, 2010, J ALZHEIMERS DIS, V22, P673, DOI 10.3233/JAD-2010-100318
hcfmusp.relation.referenceZimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028
hcfmusp.remissive.sponsorshipAstraZeneca
hcfmusp.remissive.sponsorshipLundbeck
hcfmusp.remissive.sponsorshipNIH
hcfmusp.remissive.sponsorshipOtsuka
hcfmusp.remissive.sponsorshipRoche
hcfmusp.remissive.sponsorshipServier
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication63c4cd6a-ffaa-4054-9091-d21c2e742045
relation.isAuthorOfPublicationa40013d7-b0e4-4ee4-8364-839a975e2053
relation.isAuthorOfPublication92e602aa-53f7-479f-82aa-2ca6f31b7a62
relation.isAuthorOfPublicationdf5ff348-2322-414d-9ef0-ab5deaf53a61
relation.isAuthorOfPublication28e5703a-db65-44b8-ac6c-7ac5353eb87e
relation.isAuthorOfPublication2bb09509-157a-4a18-ab59-cc751811b801
relation.isAuthorOfPublication354247b0-4a1e-4870-bbda-4da41a0fec0e
relation.isAuthorOfPublicationd75a3ac2-5bdd-4774-ad4d-ea749b1fb4d3
relation.isAuthorOfPublication881db2b4-88a7-4a44-aa3e-4e81c685eed4
relation.isAuthorOfPublication.latestForDiscovery63c4cd6a-ffaa-4054-9091-d21c2e742045
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SOBREIRO_Executive_function_and_depressive_symptoms_of_retardation_in_2014.PDF
Tamanho:
196.98 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)